{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:06:03Z","timestamp":1790625963934,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1476-4598-13-150","type":"journal-article","created":{"date-parts":[[2014,6,14]],"date-time":"2014-06-14T01:04:13Z","timestamp":1402707853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["FW-04-806 inhibits proliferation and induces apoptosis in human breast cancer cells by binding to N-terminus of Hsp90 and disrupting Hsp90-Cdc37 complex formation"],"prefix":"10.1186","volume":"13","author":[{"given":"Wei","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian-ru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun-dan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-hua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,14]]},"reference":[{"key":"1353_CR1","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nrm1492","volume":"5","author":"JC Young","year":"2004","unstructured":"Young JC, Agashe VR, Siegers K, Hartl FU: Pathways of chaperone-mediated protein folding in the cytosol. Nat Rev Mol Cell Biol. 2004, 5: 781-791. 10.1038\/nrm1492","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1353_CR2","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1098\/rstb.1993.0031","volume":"339","author":"WJ Welch","year":"1993","unstructured":"Welch WJ: Heat shock proteins functioning as molecular chaperones: their roles in normal and stressed cells. Phil Trans Roy Soc Lond B Biol Sci. 1993, 339: 327-333. 10.1098\/rstb.1993.0031.","journal-title":"Phil Trans Roy Soc Lond B Biol Sci"},{"key":"1353_CR3","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/381571a0","volume":"381","author":"FU Hartl","year":"1996","unstructured":"Hartl FU: Molecular chaperones in cellular protein folding. Nature. 1996, 381: 571-579. 10.1038\/381571a0","journal-title":"Nature"},{"key":"1353_CR4","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1517\/17460441.2011.563296","volume":"6","author":"HJ Patel","year":"2011","unstructured":"Patel HJ, Modi S, Chiosis G, Taldone T: Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment. Expet Opin Drug Discov. 2011, 6: 559-587. 10.1517\/17460441.2011.563296.","journal-title":"Expet Opin Drug Discov"},{"key":"1353_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nature01913","volume":"425","author":"A Kamal","year":"2003","unstructured":"Kamal A, Thao L, Sensintaffar J, Zhang L, Boehm MF, Fritz LC, Burrows FJ: A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature. 2003, 425: 407-410. 10.1038\/nature01913","journal-title":"Nature"},{"key":"1353_CR6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.molmed.2004.04.006","volume":"10","author":"A Kamal","year":"2004","unstructured":"Kamal A, Boehm MF, Burrows FJ: Therapeutic and diagnostic implications of Hsp90 activation. Trends Mol Med. 2004, 10: 283-290. 10.1016\/j.molmed.2004.04.006","journal-title":"Trends Mol Med"},{"key":"1353_CR7","doi-asserted-by":"publisher","first-page":"6350","DOI":"10.1016\/j.febslet.2005.10.020","volume":"579","author":"SF Falsone","year":"2005","unstructured":"Falsone SF, Gesslbauer B, Tirk F, Piccinini AM, Kungl AJ: A proteomic snapshot of the human heat shock protein 90 interactome. FEBS Lett. 2005, 579: 6350-6354. 10.1016\/j.febslet.2005.10.020","journal-title":"FEBS Lett"},{"key":"1353_CR8","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.cell.2004.12.024","volume":"120","author":"R Zhao","year":"2005","unstructured":"Zhao R, Davey M, Hsu YC, Kaplanek P, Tong A, Parsons AB, Krogan N, Cagney G, Mai D, Greenblatt J, Boone C, Emili A, Houry WA: Navigating the chaperone network: an integrative map of physical and genetic interactions mediated by the hsp90 chaperone. Cell. 2005, 120: 715-727. 10.1016\/j.cell.2004.12.024","journal-title":"Cell"},{"key":"1353_CR9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.drudis.2007.10.007","volume":"13","author":"DB Solit","year":"2008","unstructured":"Solit DB, Chiosis G: Development and application of Hsp90 inhibitors. Drug Discov Today. 2008, 13: 38-43. 10.1016\/j.drudis.2007.10.007","journal-title":"Drug Discov Today"},{"key":"1353_CR10","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nrm2918","volume":"11","author":"M Taipale","year":"2010","unstructured":"Taipale M, Jarosz DF, Lindquist S: HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nat Rev Mol Cell Biol. 2010, 11: 515-528. 10.1038\/nrm2918","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1353_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.molcel.2010.07.012","volume":"39","author":"MP Mayer","year":"2010","unstructured":"Mayer MP: Gymnastics of molecular chaperones. Mol Cell. 2010, 39: 321-331. 10.1016\/j.molcel.2010.07.012","journal-title":"Mol Cell"},{"key":"1353_CR12","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1016\/j.bmc.2012.03.043","volume":"20","author":"PF Hughes","year":"2012","unstructured":"Hughes PF, Barrott JJ, Carlson DA, Loiselle DR, Speer BL, Bodoor K, Rund LA, Haystead TA: A highly selective Hsp90 affinity chromatography resin with a cleavable linker. Bioorg Med Chem. 2012, 20: 3298-3305. 10.1016\/j.bmc.2012.03.043","journal-title":"Bioorg Med Chem"},{"key":"1353_CR13","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.chembiol.2010.04.015","volume":"17","author":"P Fadden","year":"2010","unstructured":"Fadden P, Huang KH, Veal JM, Steed PM, Barabasz AF, Foley B, Hu M, Partridge JM, Rice J, Scott A, Dubois LG, Freed TA, Silinski MA, Barta TE, Hughes PF, Ommen A, Ma W, Smith ED, Spangenberg AW, Eaves J, Hanson GJ, Hinkley L, Jenks M, Lewis M, Otto J, Pronk GJ, Verleysen K, Haystead TA, Hall SE: Application of chemoproteomics to drug discovery: identification of a clinical candidate targeting hsp90. Chem Biol. 2010, 17: 686-694. 10.1016\/j.chembiol.2010.04.015","journal-title":"Chem Biol"},{"key":"1353_CR14","first-page":"45","volume":"37","author":"C Hong","year":"2012","unstructured":"Hong C, Wei J, Wei H, Hui-ling F, Hong J, Wei Z: Optimization of fermentation conditions for FW-04-806, a macrolide dilactone compound with two oxazole ring. Chin J Antibiot. 2012, 37: 45-49.","journal-title":"Chin J Antibiot"},{"key":"1353_CR15","doi-asserted-by":"publisher","first-page":"874","DOI":"10.7164\/antibiotics.32.874","volume":"32","author":"JW Westley","year":"1979","unstructured":"Westley JW, Liu CM, Evans RH, Blount JF: Conglobatin, a novel macrolide dilactone from Streptomyces conglobatus ATCC 31005. J Antibiot. 1979, 32: 874-877. 10.7164\/antibiotics.32.874","journal-title":"J Antibiot"},{"key":"1353_CR16","first-page":"502","volume":"36","author":"H Wei","year":"2011","unstructured":"Wei H, Wei J, Hui-ling F, Hong C, Jian-hua X, Hong J, Wei Z: Structure identification and anti-tumor activity research of FW-04-806. Chin J Antibiot. 2011, 36: 502-508.","journal-title":"Chin J Antibiot"},{"key":"1353_CR17","first-page":"711","volume":"49","author":"C Jun-jie","year":"2010","unstructured":"Jun-jie C, Qiu-ju G, Xiao-meng H, Shi-xin Y, Cheng C, Lian-ru Z: Study on a Screening Model for Inhibitor of Hsp90 ATPase Activity. J Xiamen University (Nat Science). 2010, 49: 711-716.","journal-title":"J Xiamen University (Nat Science)"},{"key":"1353_CR18","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1074\/mcp.M700124-MCP200","volume":"6","author":"M Fonovic","year":"2007","unstructured":"Fonovic M, Verhelst SH, Sorum MT, Bogyo M: Proteomics evaluation of chemically cleavable activity-based probes. Mol Cell Proteomics. 2007, 6: 1761-1770. 10.1074\/mcp.M700124-MCP200","journal-title":"Mol Cell Proteomics"},{"key":"1353_CR19","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.jnutbio.2011.11.004","volume":"23","author":"Y Li","year":"2012","unstructured":"Li Y, Karagoz GE, Seo YH, Zhang T, Jiang Y, Yu Y, Duarte AM, Schwartz SJ, Boelens R, Carroll K, R\u00fcdiger SG, Sun D: Sulforaphane inhibits pancreatic cancer through disrupting Hsp90-p50(Cdc37) complex and direct interactions with amino acids residues of Hsp90. J Nutr Biochem. 2012, 23: 1617-1626. 10.1016\/j.jnutbio.2011.11.004","journal-title":"J Nutr Biochem"},{"key":"1353_CR20","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ab.2003.10.038","volume":"327","author":"MG Rowlands","year":"2004","unstructured":"Rowlands MG, Newbatt YM, Prodromou C, Pearl LH, Workman P, Aherne W: High-throughput screening assay for inhibitors of heat-shock protein 90 ATPase activity. Anal Biochem. 2004, 327: 176-183. 10.1016\/j.ab.2003.10.038","journal-title":"Anal Biochem"},{"key":"1353_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ab.2007.08.020","volume":"372","author":"L Chang","year":"2008","unstructured":"Chang L, Bertelsen EB, Wisen S, Larsen EM, Zuiderweg ER, Gestwicki JE: High-throughput screen for small molecules that modulate the ATPase activity of the molecular chaperone DnaK. Anal Biochem. 2008, 372: 167-176. 10.1016\/j.ab.2007.08.020","journal-title":"Anal Biochem"},{"key":"1353_CR22","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2174\/0929867033457818","volume":"10","author":"L Neckers","year":"2003","unstructured":"Neckers L: Development of small molecule Hsp90 inhibitors: utilizing both forward and reverse chemical genomics for drug identification. Curr Med Chem. 2003, 10: 733-739. 10.2174\/0929867033457818","journal-title":"Curr Med Chem"},{"key":"1353_CR23","doi-asserted-by":"publisher","first-page":"8324","DOI":"10.1073\/pnas.91.18.8324","volume":"91","author":"L Whitesell","year":"1994","unstructured":"Whitesell L, Mimnaugh EG, De Costa B, Myers CE, Neckers LM: Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation. Proc Natl Acad Sci U S A. 1994, 91: 8324-8328. 10.1073\/pnas.91.18.8324","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1353_CR24","doi-asserted-by":"publisher","first-page":"22796","DOI":"10.1074\/jbc.271.9.4974","volume":"271","author":"EG Mimnaugh","year":"1996","unstructured":"Mimnaugh EG, Chavany C, Neckers L: Polyubiquitination and proteasomal degradation of the p185c-erbB-2 receptor protein-tyrosine kinase induced by geldanamycin. J Biol Chem. 1996, 271: 22796-22801. 10.1074\/jbc.271.37.22796","journal-title":"J Biol Chem"},{"key":"1353_CR25","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/med.20052","volume":"26","author":"BS Blagg","year":"2006","unstructured":"Blagg BS, Kerr TD: Hsp90 inhibitors: small molecules that transform the Hsp90 protein folding machinery into a catalyst for protein degradation. Med Res Rev. 2006, 26: 310-338. 10.1002\/med.20052","journal-title":"Med Res Rev"},{"key":"1353_CR26","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/3-540-29717-0_11","volume":"172","author":"L Neckers","year":"2006","unstructured":"Neckers L: Chaperoning oncogenes: Hsp90 as a target of geldanamycin. Handb Exp Pharmacol. 2006, 172: 259-277. 10.1007\/3-540-29717-0_11","journal-title":"Handb Exp Pharmacol"},{"key":"1353_CR27","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/BF00689048","volume":"36","author":"JG Supko","year":"1995","unstructured":"Supko JG, Hickman RL, Grever MR, Malspeis L: Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent. Cancer Chemother Pharmacol. 1995, 36: 305-315. 10.1007\/BF00689048","journal-title":"Cancer Chemother Pharmacol"},{"key":"1353_CR28","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1158\/1535-7163.MCT-07-0484","volume":"7","author":"T Zhang","year":"2008","unstructured":"Zhang T, Hamza A, Cao X, Wang B, Yu S, Zhan CG, Sun D: A novel Hsp90 inhibitor to disrupt Hsp90\/Cdc37 complex against pancreatic cancer cells. Mol Cancer Ther. 2008, 7: 162-170. 10.1158\/1535-7163.MCT-07-0484","journal-title":"Mol Cancer Ther"},{"key":"1353_CR29","doi-asserted-by":"publisher","first-page":"11942","DOI":"10.1158\/0008-5472.CAN-07-3162","volume":"67","author":"PJ Gray Jr","year":"2007","unstructured":"Gray PJ, Stevenson MA, Calderwood SK: Targeting Cdc37 inhibits multiple signaling pathways and induces growth arrest in prostate cancer cells. Cancer Res. 2007, 67: 11942-11950. 10.1158\/0008-5472.CAN-07-3162","journal-title":"Cancer Res"},{"key":"1353_CR30","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nrc2420","volume":"8","author":"PJ Gray Jr","year":"2008","unstructured":"Gray PJ, Prince T, Cheng J, Stevenson MA, Calderwood SK: Targeting the oncogene and kinome chaperone CDC37. Nat Rev Cancer. 2008, 8: 491-495. 10.1038\/nrc2420","journal-title":"Nat Rev Cancer"},{"key":"1353_CR31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.gde.2004.12.011","volume":"15","author":"LH Pearl","year":"2005","unstructured":"Pearl LH: Hsp90 and Cdc37 \u2013 a chaperone cancer conspiracy. Curr Opin Genet Dev. 2005, 15: 55-61. 10.1016\/j.gde.2004.12.011","journal-title":"Curr Opin Genet Dev"},{"key":"1353_CR32","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.molcel.2006.07.016","volume":"23","author":"CK Vaughan","year":"2006","unstructured":"Vaughan CK, Gohlke U, Sobott F, Good VM, Ali MM, Prodromou C, Robinson CV, Saibil HR, Pearl LH: Structure of an Hsp90-Cdc37-Cdk4 complex. Mol Cell. 2006, 23: 697-707. 10.1016\/j.molcel.2006.07.016","journal-title":"Mol Cell"},{"key":"1353_CR33","doi-asserted-by":"publisher","first-page":"20090","DOI":"10.1074\/jbc.273.32.20090","volume":"273","author":"AM Silverstein","year":"1998","unstructured":"Silverstein AM, Grammatikakis N, Cochran BH, Chinkers M, Pratt WB: p50(cdc37) binds directly to the catalytic domain of Raf as well as to a site on hsp90 that is topologically adjacent to the tetratricopeptide repeat binding site. J Biol Chem. 1998, 273: 20090-20095. 10.1074\/jbc.273.32.20090","journal-title":"J Biol Chem"},{"key":"1353_CR34","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.cell.2012.06.047","volume":"150","author":"M Taipale","year":"2012","unstructured":"Taipale M, Krykbaeva I, Koeva M, Kayatekin C, Westover KD, Karras GI, Lindquist S: Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. Cell. 2012, 150: 987-1001. 10.1016\/j.cell.2012.06.047","journal-title":"Cell"},{"key":"1353_CR35","doi-asserted-by":"publisher","first-page":"5853","DOI":"10.1002\/anie.200900929","volume":"48","author":"S Sreeramulu","year":"2009","unstructured":"Sreeramulu S, Gande SL, Gobel M, Schwalbe H: Molecular mechanism of inhibition of the human protein complex Hsp90-Cdc37, a kinome chaperone-cochaperone, by triterpene celastrol. Angew Chem Int Ed Engl. 2009, 48: 5853-5855. 10.1002\/anie.200900929","journal-title":"Angew Chem Int Ed Engl"},{"key":"1353_CR36","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.1158\/0008-5472.CAN-05-4529","volume":"66","author":"H Yang","year":"2006","unstructured":"Yang H, Chen D, Cui QC, Yuan X, Dou QP: Celastrol, a triterpene extracted from the Chinese \u201cThunder of God Vine, \u201d is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice. Cancer Res. 2006, 66: 4758-4765. 10.1158\/0008-5472.CAN-05-4529","journal-title":"Cancer Res"},{"key":"1353_CR37","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.bcp.2009.09.017","volume":"79","author":"Y Yu","year":"2010","unstructured":"Yu Y, Hamza A, Zhang T, Gu M, Zou P, Newman B, Li Y, Gunatilaka AA, Zhan CG, Sun D: Withaferin A targets heat shock protein 90 in pancreatic cancer cells. Biochem Pharmacol. 2010, 79: 542-551. 10.1016\/j.bcp.2009.09.017","journal-title":"Biochem Pharmacol"},{"issue":"Suppl 13","key":"1353_CR38","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1186\/1471-2105-12-S13-S22","volume":"12","author":"A Grover","year":"2011","unstructured":"Grover A, Agrawal V, Shandilya A, Bisaria VS, Sundar D: Non-nucleosidic inhibition of Herpes simplex virus DNA polymerase: mechanistic insights into the anti-herpetic mode of action of herbal drug withaferin A. BMC Bioinformatics. 2011, 12 (Suppl 13): S22-10.1186\/1471-2105-12-S13-S22.","journal-title":"BMC Bioinformatics"},{"key":"1353_CR39","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1074\/jbc.M006864200","volume":"276","author":"W Xu","year":"2001","unstructured":"Xu W, Mimnaugh E, Rosser MF, Nicchitta C, Marcu M, Yarden Y, Neckers L: Sensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90. J Biol Chem. 2001, 276: 3702-3708. 10.1074\/jbc.M006864200","journal-title":"J Biol Chem"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-4598-13-150.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T04:26:09Z","timestamp":1630556769000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/1476-4598-13-150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,14]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1353"],"URL":"https:\/\/doi.org\/10.1186\/1476-4598-13-150","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,14]]},"assertion":[{"value":"15 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"150"}}